Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,953 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
8-K File 000-23186

8-K

Filing date
22 Jan 2018
Reporting date
21 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425

8-K

Filing date
22 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
05 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221421

EFFECT filing

Filing date
12 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-221421

FORM S-3/A

Filing date
04 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221421

FORM S-3

Filing date
08 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Sep 2017
Reporting date
18 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
15 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .